---
document_datetime: 2025-12-29 14:32:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/duzallo.html
document_name: duzallo.html
version: success
processing_time: 0.1067721
conversion_datetime: 2025-12-30 21:30:25.184379
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Duzallo

[RSS](/en/individual-human-medicine.xml/66815)

##### Withdrawn

This medicine's authorisation has been withdrawn

allopurinol / lesinurad Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Duzallo](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 31 July 2020, the European Commission withdrew the marketing authorisation for Duzallo (allopurinol / lesinurad) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Grunenthal GmbH, which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Duzallo was granted marketing authorisation in the EU on 23 August 2018 for gout. The marketing authorisation was initially valid for a 5-year period. The product had not been marketed in the EU since 2018.

The European Public Assessment Report (EPAR) for Duzallo is updated to indicate that the marketing authorisation is no longer valid.

Duzallo : EPAR - Medicine overview

Reference Number: EMA/455545/2018

English (EN) (668.09 KB - PDF)

**First published:** 24/08/2018

**Last updated:** 06/08/2020

[View](/en/documents/overview/duzallo-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-138)

български (BG) (780.71 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/bg/documents/overview/duzallo-epar-medicine-overview_bg.pdf)

español (ES) (684.16 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/es/documents/overview/duzallo-epar-medicine-overview_es.pdf)

čeština (CS) (751.99 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/cs/documents/overview/duzallo-epar-medicine-overview_cs.pdf)

dansk (DA) (680.84 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/da/documents/overview/duzallo-epar-medicine-overview_da.pdf)

Deutsch (DE) (684.99 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/de/documents/overview/duzallo-epar-medicine-overview_de.pdf)

eesti keel (ET) (679.15 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/et/documents/overview/duzallo-epar-medicine-overview_et.pdf)

ελληνικά (EL) (790.77 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/el/documents/overview/duzallo-epar-medicine-overview_el.pdf)

français (FR) (685.18 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/fr/documents/overview/duzallo-epar-medicine-overview_fr.pdf)

hrvatski (HR) (698.5 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/hr/documents/overview/duzallo-epar-medicine-overview_hr.pdf)

italiano (IT) (683.73 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/it/documents/overview/duzallo-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (737.62 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/lv/documents/overview/duzallo-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (704.71 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/lt/documents/overview/duzallo-epar-medicine-overview_lt.pdf)

magyar (HU) (744.31 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/hu/documents/overview/duzallo-epar-medicine-overview_hu.pdf)

Malti (MT) (752.99 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/mt/documents/overview/duzallo-epar-medicine-overview_mt.pdf)

Nederlands (NL) (684.07 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/nl/documents/overview/duzallo-epar-medicine-overview_nl.pdf)

polski (PL) (751.21 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/pl/documents/overview/duzallo-epar-medicine-overview_pl.pdf)

português (PT) (683.78 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/pt/documents/overview/duzallo-epar-medicine-overview_pt.pdf)

română (RO) (703.65 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/ro/documents/overview/duzallo-epar-medicine-overview_ro.pdf)

slovenčina (SK) (751.33 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/sk/documents/overview/duzallo-epar-medicine-overview_sk.pdf)

slovenščina (SL) (744.53 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/sl/documents/overview/duzallo-epar-medicine-overview_sl.pdf)

Suomi (FI) (683.59 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/fi/documents/overview/duzallo-epar-medicine-overview_fi.pdf)

svenska (SV) (680.84 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/sv/documents/overview/duzallo-epar-medicine-overview_sv.pdf)

Duzallo : EPAR - Risk-management-plan summary

English (EN) (742.47 KB - PDF)

**First published:** 24/08/2018

**Last updated:** 06/08/2020

[View](/en/documents/rmp-summary/duzallo-epar-risk-management-plan-summary_en.pdf)

## Product information

Duzallo : EPAR - Product Information

English (EN) (1.22 MB - PDF)

**First published:** 24/08/2018

**Last updated:** 06/08/2020

[View](/en/documents/product-information/duzallo-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-98)

български (BG) (2.19 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/bg/documents/product-information/duzallo-epar-product-information_bg.pdf)

español (ES) (1.06 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/es/documents/product-information/duzallo-epar-product-information_es.pdf)

čeština (CS) (1.8 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/cs/documents/product-information/duzallo-epar-product-information_cs.pdf)

dansk (DA) (1.06 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/da/documents/product-information/duzallo-epar-product-information_da.pdf)

Deutsch (DE) (1.08 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/de/documents/product-information/duzallo-epar-product-information_de.pdf)

eesti keel (ET) (1.05 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/et/documents/product-information/duzallo-epar-product-information_et.pdf)

ελληνικά (EL) (2.19 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/el/documents/product-information/duzallo-epar-product-information_el.pdf)

français (FR) (1.08 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/fr/documents/product-information/duzallo-epar-product-information_fr.pdf)

hrvatski (HR) (1.05 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/hr/documents/product-information/duzallo-epar-product-information_hr.pdf)

íslenska (IS) (1.06 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/is/documents/product-information/duzallo-epar-product-information_is.pdf)

italiano (IT) (1.06 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/it/documents/product-information/duzallo-epar-product-information_it.pdf)

latviešu valoda (LV) (1.83 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/lv/documents/product-information/duzallo-epar-product-information_lv.pdf)

lietuvių kalba (LT) (310.39 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/lt/documents/product-information/duzallo-epar-product-information_lt.pdf)

magyar (HU) (1.8 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/hu/documents/product-information/duzallo-epar-product-information_hu.pdf)

Malti (MT) (1.89 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/mt/documents/product-information/duzallo-epar-product-information_mt.pdf)

Nederlands (NL) (2.57 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/nl/documents/product-information/duzallo-epar-product-information_nl.pdf)

norsk (NO) (1.05 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/no/documents/product-information/duzallo-epar-product-information_no.pdf)

polski (PL) (1.84 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/pl/documents/product-information/duzallo-epar-product-information_pl.pdf)

português (PT) (1.06 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/pt/documents/product-information/duzallo-epar-product-information_pt.pdf)

română (RO) (1.09 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/ro/documents/product-information/duzallo-epar-product-information_ro.pdf)

slovenčina (SK) (1.8 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/sk/documents/product-information/duzallo-epar-product-information_sk.pdf)

slovenščina (SL) (1.76 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/sl/documents/product-information/duzallo-epar-product-information_sl.pdf)

Suomi (FI) (307.79 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/fi/documents/product-information/duzallo-epar-product-information_fi.pdf)

svenska (SV) (1.05 MB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/sv/documents/product-information/duzallo-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0002/G 31/07/2019

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Duzallo : EPAR - All Authorised presentations

English (EN) (643.98 KB - PDF)

**First published:** 24/08/2018

**Last updated:** 06/08/2020

[View](/en/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-96)

български (BG) (668.21 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/bg/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_bg.pdf)

español (ES) (644.06 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/es/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_es.pdf)

čeština (CS) (660.86 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/cs/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (644.95 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/da/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (644.9 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/de/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (644.55 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/et/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (667.74 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/el/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_el.pdf)

français (FR) (643.47 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/fr/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (643.66 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/hr/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (643.5 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/is/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_is.pdf)

italiano (IT) (643.5 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/it/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (661.54 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/lv/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (644.78 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/lt/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (660.24 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/hu/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (660.12 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/mt/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (665.04 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/nl/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (645.67 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/no/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_no.pdf)

polski (PL) (660.39 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/pl/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_pl.pdf)

português (PT) (644.36 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/pt/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_pt.pdf)

română (RO) (644.37 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/ro/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (660.88 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/sk/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (659.37 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/sl/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (644.54 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/fi/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (644.23 KB - PDF)

**First published:**

24/08/2018

**Last updated:**

06/08/2020

[View](/sv/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Duzallo Active substance

- allopurinol
- lesinurad

International non-proprietary name (INN) or common name

- allopurinol
- lesinurad

Therapeutic area (MeSH) Gout Anatomical therapeutic chemical (ATC) code M04AA51

### Pharmacotherapeutic group

Antigout preparations

### Therapeutic indication

Duzallo is indicated in adults for the treatment of hyperuricaemia in gout patients who have not achieved target serum uric acid levels with an adequate dose of allopurinol alone.

## Authorisation details

EMA product number EMEA/H/C/004412 Marketing authorisation holder

Grunenthal GmbH

Zieglerstrasse 6

Opinion adopted 28/06/2019 Marketing authorisation issued 23/08/2018 Revision 2

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Duzallo : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (728.91 KB - PDF)

**First published:** 08/10/2019

**Last updated:** 06/08/2020

[View](/en/documents/procedural-steps-after/duzallo-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Duzallo : EPAR - Public assessment report

Reference Number: EMA/474026/2018

English (EN) (5.17 MB - PDF)

**First published:** 24/08/2018

**Last updated:** 06/08/2020

[View](/en/documents/assessment-report/duzallo-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Duzallo

Adopted

Reference Number: EMA/CHMP/374196/2018

English (EN) (645.28 KB - PDF)

**First published:** 29/06/2018

**Last updated:** 06/08/2020

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-duzallo_en.pdf)

#### News on Duzallo

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 June 2018](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-25-28-june-2018) 29/06/2018

**This page was last updated on** 06/08/2020

## Share this page

[Back to top](#main-content)